Richter And Bio-Thera Shake Hands On $100m+ European Ustekinumab Deal

Hikma Remains Licensee Of BAT2206 Stelara Biosimilar In The US

 
• By Dave Wallace
  
China’s Bio-Thera has agreed a European licensing deal with Gedeon Richter (Shutterstock)

More from Deals

More from Products